Charles River Laboratories International, Inc. (CRL)
298.58
+3.39
(+1.15%)
USD |
NYSE |
Aug 24, 16:00
298.74
+0.16
(+0.05%)
After-Hours: 20:00
Charles River Laboratories International Market Cap : 14.25B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 14.25B |
| August 21, 2026 | 14.09B |
| August 20, 2026 | 13.91B |
| August 19, 2026 | 13.84B |
| August 18, 2026 | 13.33B |
| August 17, 2026 | 13.68B |
| August 14, 2026 | 13.37B |
| August 13, 2026 | 13.42B |
| August 12, 2026 | 13.57B |
| August 11, 2026 | 13.46B |
| August 10, 2026 | 13.22B |
| August 07, 2026 | 12.77B |
| August 06, 2026 | 12.67B |
| August 05, 2026 | 12.44B |
| August 04, 2026 | 11.17B |
| August 03, 2026 | 11.02B |
| July 31, 2026 | 11.20B |
| July 30, 2026 | 11.30B |
| July 29, 2026 | 11.31B |
| July 28, 2026 | 11.58B |
| July 27, 2026 | 10.80B |
| July 24, 2026 | 10.91B |
| July 23, 2026 | 11.04B |
| July 22, 2026 | 10.53B |
| July 21, 2026 | 10.57B |
| Date | Value |
|---|---|
| July 20, 2026 | 10.58B |
| July 17, 2026 | 10.81B |
| July 16, 2026 | 11.04B |
| July 15, 2026 | 10.99B |
| July 14, 2026 | 11.14B |
| July 13, 2026 | 11.07B |
| July 10, 2026 | 11.24B |
| July 09, 2026 | 11.25B |
| July 08, 2026 | 10.79B |
| July 07, 2026 | 11.01B |
| July 06, 2026 | 11.15B |
| July 02, 2026 | 11.11B |
| July 01, 2026 | 11.03B |
| June 30, 2026 | 10.92B |
| June 29, 2026 | 10.87B |
| June 26, 2026 | 10.39B |
| June 25, 2026 | 10.25B |
| June 24, 2026 | 9.735B |
| June 23, 2026 | 8.988B |
| June 22, 2026 | 8.745B |
| June 18, 2026 | 8.911B |
| June 17, 2026 | 8.783B |
| June 16, 2026 | 8.901B |
| June 15, 2026 | 9.078B |
| June 12, 2026 | 9.032B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| IQVIA Holdings, Inc. | 42.84B |
| Medpace Holdings, Inc. | 17.26B |
| Fortrea Holdings, Inc. | 1.741B |
| Avantor, Inc. | 9.647B |
| Champions Oncology, Inc. | 69.02M |
Market Cap Related Metrics
| PS Ratio | 3.651 |
| PEG Ratio | -0.2311 |
| Price to Book Value | 5.018 |
| Price to Free Cash Flow | 39.40 |
| Price | 298.58 |
| Earnings Yield | -1.63% |
| PEGY Ratio | -0.2311 |
| Operating PE Ratio | 27.02 |
| Normalized PE Ratio | 158.69 |